The refractory epilepsy screening tool for Lennox–Gastaut syndrome (REST-LGS) - ScienceDirect
Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial - The Lancet
These are the causes of Lennox gastaut syndrome - MEDizzy
Prevalence, healthcare resource utilization and mortality of Lennox-Gastaut syndrome: retrospective linkage cohort study
Epileptic encephalopathies: de novo mutations take center stage | Beyond the Ion Channel
Global Lennox-Gastaut Syndrome Treatment Market 2022-2026
Treatment algorithm for a newly diagnosed patient with LGS. a Not in... | Download Scientific Diagram
Early Diagnosis and Treatment of Lennox-Gastaut Syndrome - Trevor Resnick, Raj D. Sheth, 2017
Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox–Gastaut syndrome: Interim analysis of an open‐label extension study - Knupp - 2023 - Epilepsia - Wiley Online Library
Treatment of Lennox-Gastaut Syndrome (LGS) - ScienceDirect
Expanding the Treatment Landscape for Lennox-Gastaut Syndrome: Current and Future Strategies | SpringerLink
Symptoms
Cannabidiol for Drop Attacks in Lennox–Gastaut Syndrome
Early Diagnosis and Treatment of Lennox-Gastaut Syndrome - Trevor Resnick, Raj D. Sheth, 2017